Todos Medical appoints new VPs for sales and sales operations

Todos Medical Ltd (OTCQB:TOMDF) said it has appointed Marsha Fontanive as vice president of sales and Chris Gross and as vice president of sales operations. The in-vitro diagnostics company, which focuses on solutions for coronavirus screening and diagnosis and developing blood tests for the early detection of cancer and Alzheimer’s disease, said the two new appointees will be working to “significantly increase” its national sales capabilities by delivering a 25-person salesforce of seasoned laboratory sales representatives to market its combination of coronavirus testing equipment, reagents and supplies to national and international markets. READ: Todos Medical sees strong sales and surging demand for its COVID-19 testing kits in the US Fontanive is currently president of Expansion Medical Consulting, a consulting company she founded in 2010, while Gross previously served as managing director and co-founder of consumer healthcare firm WellNova. “Todos has quietly built a tremendous portfolio of products that are sorely needed in the CLIA laboratory marketplace to increase the capacity for [coronavirus] testing in the United States. As the incoming team, we are well-positioned to compete with more well-established competitors who are unable to meet the intense market need for full solutions that allow for rapid expansion of molecular testing capacity in the United States”, Fontanive said in a statement. Gross added: “We are excited with the [coronavirus] solutions Todos is putting together. At a time when we expect tremendous growth in Todos’ sales, we are focused on helping the sales operations scale to meet the significant pressure we expect in the months ahead. With proprietary testing solutions that address PCR, antigen and antibody testing, as well as Todos’ innovative 3C protease fluorescence assays that it will begin to bring to market that really fill in the potential life cycle of [coronavirus] testing, we see tremendous potential to capture market share for Todos.” “We believe we have found the right team to take Todos’ sales to the next level,” “With Chris and Marsha on board, we can now focus on expanding our sales networks rapidly and deploying our testing solutions to address the lack of intelligent [coronavirus] testing nationwide”, said Todos president and chief executive Gerald E. Commissiong. Contact the author at calum@proactiveinvestors.com Follow him on Twitter @Cal_Proac